$1.66
-0.0227-1.35%
Last update: Oct 23, 11:21 AM
Biomerica Inc (BMRA) Stock Price, Quote, News & History
BMRANASDAQ
Biomerica's Fortel PSA test gains UAE approval for prostate cancer detection. Q2 shows 5% sales growth and reduced losses through cost optimization.
You can purchase shares of Biomerica (NASDAQ:BMRA) through any online brokerage.
Other companies in Biomerica’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
There is no analysis for Biomerica to provide a consensus price target.
The stock price for Biomerica (NASDAQ: BMRA) is $1.6573 last updated October 23, 2026 at 11:21 AM EDT.
There are no upcoming dividends for Biomerica.
Biomerica does not have any upcoming earnings scheduled.
There is no upcoming split for Biomerica.
Biomerica is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal...
